Reduz peso e ingesta? Reduz IMT

Figure 1. Effectiveness parameters. (A) Carotid intima-media thickness (mm) variation by visit, all patients (T0, n = 40; T4, n = 40). (B) HbA1c (%) variation by visit, all patients (T0, n = 40; T4, n = 40). cIMT: carotid intima-media thickness. Paired samples t-test; *** p < 0.001.

.

https://doi.org/10.3390/biomedicines11051362

.

Conclusions: Our findings suggest the effect of injectable semaglutide on atherosclerosis as a key CV protective mechanism.

.

Glycemic parameters:
Glycemia (mg/dL)	176 ± 75	122 ± 22	<0.001
HbA1c (%)	9 ± 2	7 ± 1	<0.001

Carotid IMT

1 ± 0.1

0.9 ± 0.1

<0.001

IMT voltando como marcador de risco cardiovascular e marcador substituto.